Susan C. Galbraith, MD
NPI 1770565335ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Dayton, OH
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Dayton, Ohio, licensed in OH, with an NPI issued in November 2005. Ipsen Biopharmaceuticals, Inc reported $30.99 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1770565335 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Nov 18, 2005 |
| Last updated in NPPES | Jun 1, 2010 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 35070085 | OH |
| Internal Medicine, Nephrology | 207RN0300X | 44502 | OH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$30.99 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $30.99 | 1 |
What the 2025 payments were for
- Food and Beverage$30.99 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Dayton
- 1417130337
- 1760681712
- 1023536687
- 1083410039
- 1477746071
- 1639367162
- 1811953680
- 1205137858
- 1235159559
- 1649386764
- 1679695985
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Ohio →